French Consortium Pioneers New AMR Development Model
Executive Summary
A new consortium that has won funding from the French government will focus on developing new treatments, diagnostics and surveillance and make sure that these approaches are properly valued by involving health economists in new drug development.
You may also be interested in...
EMA Aligns Antibiotics Guideline To Help Facilitate Global Trials
The EU regulator says it supports a globally aligned approach to the development of new antimicrobial medicines.
Support For Small Companies In AMR Space Is Crucial Now
G7 countries should look to US PASTEUR Act For Inspiration On Pull Incentives for Antimicrobials
US PASTEUR Act Promises More Than Other National AMR Initiatives
PASTEUR Act in the US is the most promising initiative out there to address antimicrobial resistance.